Kraig Biocraft Laboratories Announces New Spider Silk Production Contract
08 juil. 2024 07h05 HE
|
Kraig Biocraft Laboratories
Kraig Labs (OTCQB:KBLB) signs production agreement for its recombinant spider silk technology, building on its new spider silk production hybrids success
Monthly information on share capital and company voting rights
05 juil. 2024 16h30 HE
|
Cellectis Inc.
(Article 223-16 of General Regulation of the French financial markets authority) PARIS, July 05, 2024 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number...
Olon Group Announces the Acquisition of GTP Bioways Group
03 juil. 2024 04h30 HE
|
Olon SpA
OLON GROUP ANNOUNCES THE ACQUISITION
OF GTP BIOWAYS GROUP
GTP Bioways Group is a French company operating as Biotech CDMO (Contract Developing and Manufa
Pneumagen Highlights Broad-Spectrum Antiviral Activity of First-in-Class Intranasal Drug Neumifil in New Publication
03 juil. 2024 04h00 HE
|
Pneumagen Ltd
Pneumagen has previously reported positive results from both Phase 1 and a clinical proof of concept Phase 2 Human Influenza Challenge study demonstrating the potential of NeumifilNew preclinical...
Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD
03 juil. 2024 01h00 HE
|
Regeneron Pharmaceuticals, Inc.
First-in-world approval of Dupixent for adults with uncontrolled COPD with raised blood eosinophils based on two landmark Phase 3 trials showing Dupixent significantly reduced exacerbations, improved...
Accomplished Biotech Leader Michel Dahan Joins Alkeus as President and CEO
02 juil. 2024 08h30 HE
|
Alkeus Pharmaceuticals
Alkeus Pharmaceuticals, Inc. announced today that Michel Dahan has joined the company as President and Chief Executive Officer.
Vaxcyte Appoints John Furey to Board of Directors
02 juil. 2024 08h30 HE
|
Vaxcyte, Inc.
Vaxcyte appoints John Furey to Board of Directors.
Endeavor Venture Funds and Keiretsu Forum Forge Strategic Alliance to Enhance Early-Stage Investment Opportunities
02 juil. 2024 07h05 HE
|
Keiretsu Forum Mid-Atlantic
PHILADELPHIA, July 02, 2024 (GLOBE NEWSWIRE) -- Endeavor Venture Funds and Keiretsu Forum Mid-Atlantic, South-East, and Texas announce a key strategic alliance aimed at increasing investment...
Penicillin Drug Market Is Expected To Reach a Revenue Of USD 13.4 Bn By 2033, at 3.8% CAGR: Dimension Market Research
01 juil. 2024 11h48 HE
|
Dimension Market Research
New York, July 01, 2024 (GLOBE NEWSWIRE) -- Overview The global Penicillin Drug Market is predicted to reach a size of over USD 9.6 billion by 2024, and then it is expected to grow to more than USD...
23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel
28 juin 2024 07h00 HE
|
23andMe, Inc.
SOUTH SAN FRANCISCO, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading preventive health and therapeutics company, and Nightingale Health Plc, a pioneer in...